SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has announced the appointment of Sarah M. Romano as chief financial officer, effective August 3, 2026. Romano, who is based in the United States, brings over two decades of finance leadership experience in the medical technology and life sciences sectors. She will help lead the company's financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.
Most recently, Romano served as CFO of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet, and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising over $100 million through public and private financings while overseeing strategic transactions, SEC reporting, and investor relations. Her experience in capital markets and financial strategy is expected to be instrumental as SS Innovations seeks to scale its operations and bring its robotic surgical system to new markets.
The appointment comes at a critical time for SS Innovations, which aims to make robotic surgery affordable and accessible globally. The company's flagship product, the SSi Mantra surgical robotic system, is designed to support a variety of procedures, including cardiac surgery. Achieving U.S. FDA approval would mark a significant milestone, potentially opening the door to the large American healthcare market. The company's comprehensive suite of SSi Mudra surgical instruments complements the system, offering versatility for surgeons.
SS Innovations, an American company headquartered in India, has been expanding its global footprint. The addition of Romano to the executive team signals a focus on financial discipline and strategic growth. Her track record of raising capital and managing financial operations in the life sciences sector aligns with the company's objectives to enhance its balance sheet and pursue regulatory approvals.
For more details, the full press release is available at https://ibn.fm/pAqlP. The latest news and updates relating to SSII can be found in the company's newsroom at https://ibn.fm/SSII.
This executive appointment underscores SS Innovations' commitment to strengthening its leadership team as it navigates the regulatory landscape and aims to democratize access to robotic surgery. With Romano's experience, the company is poised to execute on its strategic priorities and drive shareholder value.
